Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
3-hydroxy-3-methylglutaryl-CoA reductase | 0.529 | 0.692 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 5 | 9 | 2009 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
7-dehydrocholesterol reductase | 0.500 | 0.846 | 3.9E-13 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2012 | 2019 | |||||||||
|
acyl-CoA dehydrogenase long chain | 0.736 | 0.462 | 1.7E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
acyl-CoA dehydrogenase short chain | 0.663 | 0.538 | 2.8E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
ADAM metallopeptidase domain 12 | 0.565 | 0.731 | 5.7E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
adrenoceptor beta 3 | 0.533 | 0.731 | 2.5E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
aggrecan | 0.528 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | ||||||||
|
AKT serine/threonine kinase 3 | 0.512 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
aldehyde dehydrogenase 1 family member A2 | 0.578 | 0.692 | 0.36 |
|
phenotype | 0.100 | None | 1.000 | 6 | 19 | 2009 | 2018 | ||||||||
|
ALMS1 centrosome and basal body associated protein | 0.559 | 0.808 | 4.5E-60 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2012 | 2012 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | ||||||||
|
APOA1 antisense RNA | 0.760 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2012 | 2012 | |||||||||
|
APOC4-APOC2 readthrough (NMD candidate) | 0.821 | 0.308 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2018 | |||||||||
|
apolipoprotein A1 | 0.429 | 0.885 | 5.5E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
apolipoprotein A5 | 0.587 | 0.615 | 5.6E-10 |
|
phenotype | 0.100 | None | 1.000 | 2 | 8 | 2012 | 2019 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
phenotype | 0.100 | None | 1.000 | 5 | 27 | 2009 | 2019 | ||||||||
|
apolipoprotein C1 | 0.581 | 0.577 | 0.22 |
|
phenotype | 0.100 | None | 1.000 | 2 | 4 | 2012 | 2019 | ||||||||
|
apolipoprotein C3 | 0.531 | 0.731 | 1.0E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
apolipoprotein C4 | 0.743 | 0.385 | 8.9E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2018 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 2 | 4 | 2012 | 2019 | ||||||||
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 | 0.722 | 0.192 | 8.3E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2017 | ||||||||
|
arrestin beta 1 | 0.588 | 0.846 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 |